Francis J. Pierciey
Bluebird Bio (United States)(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Virus-based gene therapy research, Prenatal Screening and Diagnostics, CRISPR and Genetic Engineering, Bone and Joint Diseases
Most-Cited Works
- → Rapid diversification of coevolving marine Synechococcus and a virus(2012)204 cited
- → Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease(2020)141 cited
- → Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease(2014)117 cited
- → Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study(2022)102 cited
- → Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy(2024)98 cited
- → PKR-Like Endoplasmic Reticulum Kinase Is Necessary for Lipogenic Activation during HCMV Infection(2013)81 cited
- → Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients(2018)80 cited
- → Prostaglandin E2 Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells(2017)74 cited
- → Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery(2019)73 cited
- → Human Cytomegalovirus Induces the Endoplasmic Reticulum Chaperone BiP through Increased Transcription and Activation of Translation by Using the BiP Internal Ribosome Entry Site(2010)41 cited